Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Shares Up 7.7 Percent on New USPS Instrument Placements

NEW YORK, Jan. 25 (GenomeWeb News) - Shares in Cepheid were up 7.71 percent, or $.68, at $9.50 in late-afternoon trading after the company said it received an order from the US Postal Service for 300 additional anthrax-detection modules.

The news also caused Pacific Growth Equities today to upgrade Cepheid stock to "overweight" from "equal weight."

 

As GenomeWeb News reported this morning, Cepheid said the USPS will use the instruments, which are based on the firm's GeneXpert PCR technology, at mail processing centers in the United States.

 

The USPS will use them with Biohazard Detection Systems developed by  Northrop Grumman's Security Systems to detect biological threats for the USPS. The new order is part of the second phase of the project, with modules being installed starting in April. At present, the company is shipping and installing 800 GeneXpert modules that were ordered for the first phase of the project.

 

Cepheid expects an additional order of 300 modules later this year. In total, detection systems are planned for 283 mail processing centers throughout the US.

 

Pacific Growth Equities said it now expects Cepheid to post $71.9 million in first-quarter revenue. It had originally expected the company to generate $61.9 million in revenue.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.